文献速递消化内镜

预测内镜检查患者高清醒镇静需求风险评分工具的创建

Creation of a score to predict risk of high conscious sedation requirements in patients undergoing endoscopy.
PubMed 文献 · Gastrointest Endosc · 2019-11-19

本研究纳入接受内镜医师主导清醒镇静的内镜检查患者,以镇静失败(高剂量镇静、需拮抗剂、患者耐受差或手术中止)为主要结局,将488例镇静失败患者与976例对照按内镜医师和检查日期匹配。基于年龄、性别、非氯硝西泮苯二氮䓬类药物使用、阿片类药物使用和手术类型5个变量构建HCSR评分,预测镇静失败的曲线下面积为0.70,验证组(250例病例和250例对照)曲线下面积为0.68(95%CI 0.63-0.72)。

要点

  • HCSR评分基于年龄、性别、苯二氮䓬类/阿片类药物使用和手术类型5个变量。
  • 评分≥3.5者镇静失败风险最高,比值比为17.31(P=2×10^-14)。
  • 该评分可用于内镜检查前与患者讨论镇静方案。

核心结论

  • 基于5个患者和手术特征的HCSR风险评分可预测内镜检查镇静失败风险,有助于医师在检查前与患者讨论镇静选择。

研究设计与样本

  • 研究纳入接受内镜医师主导清醒镇静的内镜检查患者,镇静失败组488例按内镜医师和检查日期与对照组976例匹配。
  • 主要结局为镇静失败,定义为高剂量镇静、需苯二氮䓬类/麻醉剂拮抗剂、护士记录患者耐受差或手术中止之一。
  • 高剂量镇静定义为咪达唑仑>10 mg和/或芬太尼>200 μg或哌替啶等效剂量。
  • 验证组包含250例病例和250例对照。

主要发现

  • 与镇静失败显著相关的因素为年龄、性别、非氯硝西泮苯二氮䓬类药物使用、阿片类药物使用和手术类型(胃镜、结肠镜或两者)。
  • HCSR评分预测镇静失败的曲线下面积为0.70。
  • 与风险评分为0的患者相比,评分≥3.5的患者镇静失败风险最高(比值比17.31;P=2×10^-14)。
  • 验证组中HCSR评分的估计曲线下面积为0.68(95%CI 0.63-0.72)。

关键数值与推荐

  • 高剂量镇静定义:咪达唑仑>10 mg和/或芬太尼>200 μg或哌替啶等效剂量。
  • 镇静失败定义包含高剂量镇静、需拮抗剂、护士记录耐受差或手术中止。
  • HCSR评分≥3.5对应镇静失败比值比17.31(P=2×10^-14)。

临床怎么用

  • 内镜检查前可使用HCSR评分评估患者镇静失败风险,辅助与患者讨论镇静方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The administration of intravenous conscious sedation to patients undergoing GI endoscopy carries a risk of cardiopulmonary adverse events. Our study aim was to create a score that stratifies the risk of occurrence of either high-dose conscious sedation requirements or a failed procedure. METHODS: Patients receiving endoscopy via endoscopist-directed conscious sedation were included. The primary outcome was occurrence of sedation failure, which was defined as one of the following: (1) high-dose sedation, (2) the need for benzodiazepine/narcotic reversal agents, (3) nurse-documented poor patient tolerance to the procedure, or (4) aborted procedure. High-dose sedation was defined as >10 mg of midazolam and/or >200 μg of fentanyl or the meperidine equivalent. Patients with sedation failure (n = 488) were matched to controls (n = 976) without a sedation failure by endoscopist and endoscopy date. RESULTS: Significant associations with sedation failure were identified for age, sex, nonclonazepam benzodiazepine use, opioid use, and procedure type (EGD, colonoscopy, or both). Based on these 5 variables, we created the high conscious sedation requirements (HCSR) score, which predicted the risk of sedation failure with an area under the curve of 0.70. Compared with the patients with a risk score of 0, risk of a sedation failure was highest for patients with a score ≥3.5 (odds ratio, 17.31; P = 2 × 10-14). Estimated area under the curve of the HCSR score was 0.68 (95% confidence interval, 0.63-0.72) in a validation series of 250 cases and 250 controls. CONCLUSIONS: The HCSR risk score, based on 5 key patient and procedure characteristics, can function as a useful tool for physicians when discussing sedation options with patients before endoscopy.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. McCain JD, Stancampiano FF, Bouras EP, et al. Creation of a score to predict risk of high conscious sedation requirements in patients undergoing endoscopy. Gastrointest Endosc. 2019. PMID: 31756314. doi:10.1016/j.gie.2019.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。